Diebold Nixdorf DBD Q1 2026 Earnings EPS Beats Estimates as Operational Improvements Drive Profitability Tokenization Could Allow Investors to Shop for Yield Says Strategys Michael Saylor Vivani Medical Q1 2026 Earnings Slight EPS Beat Fails to Stem Stock Decline as PreRevenue Biotech Navigates Development Pipeline Tesla Inc Faces Sentiment Shift as Prominent Investor Graham Stephan Alters His View SEBI Proposes Overhaul of IPO Price Discovery Mechanism Amid Distortion Concerns PRGS Q1 2026 Earnings Modest EPS Beat Fails to Lift Shares